Clinical Trial

Genetic Risks for Childhood Cancer Complications in Switzerland

Study acronym: GECCOS
Recruiting
View on ClinicalTrials.gov →
Summary
The objectives of the GECCOS project are to identify genetic variants associated with complications of childhood cancer using genotype-phenotype association studies. Germline genetic samples and data of the "Germline DNA Biobank for Childhood Cancer and Blood Disorders Switzerland" (BISKIDS) which is included in the Geneva Biobank for Hematology and Oncology in Pediatrics (BaHOP) will be used with clinical data of Swiss childhood cancer patients collected at the Institute of Social and Preventive Medicine in Bern.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-01-07.
Trial Details
NCT Number NCT04702321
Lead Sponsor University Hospital, Geneva
Conditions Childhood Cancer, Genetic Predisposition, Late Effect
Enrollment 6,000 participants
Start Date 2020-12-01
Primary Completion 2037-12-31 (estimated)
Study Completion 2037-12-31 (estimated)
Updated on ClinicalTrials.gov 2021-01-13